J Auer1, R Berent, C Punzengruber
1II. Interne Abteilung mit Kardiologie und Internistische Intensivmedizin, Allgemeines Krankenhaus Wels, Grieskirchnerstrasse 42, A-4600 Wels. johann.auer@khwels.at
Intravascular brachytherapy significantly reduces restenosis after coronary interventions, including in-stent restenosis, for up to two years. However, risks include reinterventions and late thrombosis, limiting its use primarily to in-stent restenosis treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: